alexa Generating Aptamers for Cancer Diagnosis and Therapy
ISSN: 2161-1459

Journal of Clinical & Experimental Pharmacology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Generating Aptamers for Cancer Diagnosis and Therapy

Marolt U1, Cencic A1*, Gorenjak M2 and Potrc S1

1Department of Abdominal and General Surgery, UKC Maribor, Ljubljanska 5, 2000 Maribor, Eu-slovenia

2Department of Biochemistry and Nutrition, Faculty of Medicine, University of Maribor, Eu-slovenia

*Corresponding Author:
Avrelija Cencic
Faculty of Medicine
Department of Biochemistry and Nutrition
University of Maribor, Eu-slovenia
Tel: 0038623305871
E-mail: [email protected]

Received date: May 21, 2012; Accepted date: June 21, 2012; Published date: June 22, 2012

Citation: Marolt U, Cencic A, Gorenjak M, Potrc S (2012) Generating Aptamers for Cancer Diagnosis and Therapy. Clin Exp Pharmacol 2:111.doi: 10.4172/2161-1459.1000111

Copyright: © 2012 Marolt U. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



Aptamers are single-stranded dna or rna oligonucleotides or peptides that are capable of binding to specific target proteins. Aptamers are generated in a process named selex or cell-selex. They resemble antigens in respect of their highly specific binding in the lower nanomolar and/or picomolar range. In contrast to antibodies, they can be generated in vitro, are more stable molecules and have less immunogenicity, better tissue penetration and faster clearance. Aptamers can be applied in many conditions, one of them being cancer medicine, because of their ability to detect cell-specific markers within complex systems that have no specified target molecules. Moreover, aptamers can be used as therapeutic agents, which are indirectly or directly conjugated with drugs, due to their toxic, inhibitory or activating effect on target cells


Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version